Verve Therapeutics (United States)

Recent papers from Verve Therapeutics (United States)

1. Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South AsiansJournal of the American College of Cardiology · 2020
2. Rare Genetic Variants Associated With Sudden Cardiac Death in AdultsJournal of the American College of Cardiology · 2019
3. From Muscle to Mind: A Metabolic Allocation Theory of Human Hair Distribution2026
4. Gene therapy and genome editing for lipoprotein disordersEuropean Heart Journal · 2025
5. Abstract CT253: First in India, phase 1/2 study of an indigenously adapted, cost-efficient autologous dual-target BCMA/CD19 CAR T-cell therapy for relapsed or refractory multiple myelomaCancer Research · 2026
6. Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care BiobankCirculation Genomic and Precision Medicine · 2026
7. WCN26-6783 ORIGIN EXTEND: A LONG-TERM EXTENSION STUDY OF ATACICEPT IN IgA NEPHROPATHYKidney International Reports · 2026
8. The OurHealth Study: A digital genomic cohort for cardiometabolic risk mechanisms in US South Asiansnpj Digital Medicine · 2026
9. The 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP2025
10. Engineered chimeric T7 RNA polymerase improves salt tolerance and reduces dsRNA impurity generation during in vitro transcription of mRNANucleic Acids Research · 2025
11. Familial Hypercholesterolemia Screening in Childhood and Early AdulthoodJAMA · 2025
12. Familial Hypercholesterolemia Screening in Childhood and Early AdulthoodJAMA · 2025
13. Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction–Associated Steatotic Liver Disease ( MASLD )Alimentary Pharmacology & Therapeutics · 2025
14. Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy–Related CardiomyopathiesJAMA Cardiology · 2025
15. Hispanic/Latino ethnic background and genetic ancestry in relation to atherosclerotic cardiovascular disease risk estimation: Findings from the Multi-Ethnic Study of Atherosclerosis (MESA)American Journal of Preventive Cardiology · 2025
16. Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acidsEuropean Heart Journal · 2025
17. A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS)Trials · 2025
18. Ion Mobility Gas-Phase Separation Enhances Top-Down Mass Spectrometry of Heavily Modified Guide RNAAnalytical Chemistry · 2025
19. Solanum pan-genetics reveals paralogues as contingencies in crop engineeringNature · 2025
20. Triazole-Estradiol Analogs Induce Apoptosis and Inhibit EGFR and Its Downstream Pathways in Triple Negative Breast CancerMolecules · 2025